Nocturia in arterial hypertension: a prevalent, underreported, and sometimes underestimated association

详细信息    查看全文

• 作者：Carlos A. Feldstein ; MD ; ^{carlos.feldstein@yahoo.com}
• 关键词：Nocturia ; hypertension ; morbidity ; mortality ; epidemiology ; antihypertensive agents
• 刊名：Journal of the American Society of Hypertension
• 出版年：2013
• 出版时间：January-February, 2013
• 年：2013
• 卷：7
• 期：1
• 页码：75-84
• 全文大小：215 K

文摘

Nocturia is a risk factor for morbidity and mortality but is frequently overlooked and underreported by patients and unrecognized by physicians. Epidemiologic studies reported that nocturnal voiding is associated not only with aging and benign prostatic hyperplasia, but also with many other clinical conditions. The majority of epidemiologic studies reported a significant relationship between nocturia and hypertension. However, the cause-and-effect relationship between them has not been established. Some physiopathological changes in hypertension are conducive to result in nocturia. These include the effects of hypertension on glomerular filtration and tubular transport, resetting of the kidney pressure-natriuresis relationship, atrial stretch and release of atrial natriuretic peptide when congestive heart failure complicates hypertension, and peripheral edema. Another link between hypertension and nocturia is obstructive sleep apnea. Furthermore, some evidence supports the relationship between nondipping behavior of blood pressure and an increased prevalence of nocturia. The use of some classes of antihypertensive agents may result in nocturia. The present review aims to provide a comprehensive evaluation of the epidemiologic evidence and physiopathological links that correlate hypertension and nocturia. Emphasis is placed on the need to take a pro-active attitude to detect and treat this hazardous condition.